Health officials in the United Arab Emirates announced Wednesday that a Chinese vaccine provides 86% efficacy against COVID-19 infection.
阿拉伯聯合大公國的衛生官員星期三宣布，中國的疫苗對COVID-19的有效性為86%。
Subsequently, the UAE's Ministry of Health and Prevention officially pushed for a registration of the Sinopharm vaccine following several health agencies' analysis of late-stage trials in the country, officials said in a release on the state-run WAM news agency.
隨後，阿聯衛生和預防部官員在官方媒體WAM新聞社發布的消息中說，在幾家衛生機構對該國晚期試驗進行分析後，阿聯衛生和預防部正式推動了國藥疫苗的註冊。
"The announcement is a significant vote of confidence by the UAE's health authorities in the safety and efficacy of this vaccine," the health ministry said.
阿聯衛生部說：「這一宣布是阿聯衛生當局對這種疫苗的安全性和有效性的一次重大信任選擇。」。
The country approved the vaccine for emergency use in September for certain groups. It conducted a trial of the vaccine involving 31,000 volunteers from 125 nationalities in the UAE. The study reflected "no serious safety concerns," according to the health ministry, but no detailed data from the study was publicly available.
該國於9月份批准將疫苗緊急用於某些人群。它對來自阿聯125個國家的31000名志願者進行了疫苗試驗。衛生部稱，這項研究反映出「沒有嚴重的安全隱患」，但沒有公開研究的詳細數據。
It's unclear, based on this latest development however, what the UAE's next steps will be. There was no elaboration on the progression toward a potential nationwide deployment of the Sinopharm vaccine.
然而，根據這一最新進展，尚不清楚阿聯下一步將採取什麼行動。目前還沒有詳細說明在全國範圍內推廣國藥疫苗的進展情況。
The Chinese state-owned company is still conducting late-stage clinical trials in 10 countries, including Egypt, Jordan, and Argentina.
這家中國國有企業仍在埃及、約旦和阿根廷等10個國家進行後期臨床試驗。
Later this month, Morocco says it plans to implement an ambitious COVID-19 immunization program using the Sinopharm vaccine. The country is aiming to vaccinate 80% of adults, according to The Associated Press.
本月晚些時候，摩洛哥表示，計劃利用國藥集團的疫苗實施一項雄心勃勃的COVID-19免疫計劃。據美聯社報導，該國計劃為80%的成年人接種疫苗。
News of UAE's approval of the vaccine comes just a day after the U.K. launched its own nationwide immunization program. The U.S. Food and Drug Administration also said Tuesday that the COVID-19 vaccine from Pfizer and its partner BioNTech presented "no specific safety concerns" to preclude an emergency use approval, paving the way for an expected green-light later this month.
UAE批准疫苗的消息就在英國發起集體免疫計劃的第二天。美國食品和藥物管理局周二還表示，輝瑞公司及其合作夥伴BioNTech公司生產的COVID-19疫苗「沒有具體的安全隱患」，因此無法獲得緊急使用許可，這為本月晚些時候有望獲得批准鋪平了道路。
The UAE said as of Tuesday there were 8,260 confirmed new COVID-19 cases in the country.
阿聯表示，截至周二，該國共有8260例確診新的COVID-19病例。